To Determine Bioequivalence Under Fed Conditions Clinical Trial
Official title:
Randomized, Open Label, Two-sequence, Two-treatment, Two-period, Crossover, Single Dose Bioequivalence Study Fixed-dose Combination of Metformin and Vildagliptin Tablets 850/ 50 mg Manufactured by Oman Pharmaceuticals Products Co. LLC, Sultanate of Oman, With EUCREAS® 50/850mg Tablets Manufactured by Novartis Pharma GmbH, Germany, in Normal, Healthy, Adult, Male Human Subjects Under Fed Conditions.
To evaluate and compare the relative bioavailability and therefore the bioequivalence of fixed dose combination of Metformin and Vildagliptin Tablets 850/50 mg manufactured by Oman Pharmaceuticals Products Co. LLC, Sultanate of Oman, with EUCREAS® 50/850mg tablets manufactured by Novartis Pharma GmbH, Germany, in Normal, Healthy, Adult, Male Human Subjects under Fed Conditions.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00652600 -
Bioavailability Study of Propranolol Under Fed Conditions
|
Phase 1 | |
Completed |
NCT01380496 -
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions
|
Phase 1 | |
Completed |
NCT00652821 -
Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions
|
Phase 1 | |
Completed |
NCT00652873 -
Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fed Conditions
|
Phase 1 | |
Completed |
NCT00652704 -
Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions
|
Phase 1 | |
Completed |
NCT00652730 -
Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions
|
Phase 1 | |
Completed |
NCT05329857 -
The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated.
|
N/A | |
Completed |
NCT00653003 -
Bioavailability Study of Leflunomide Tablets Under Fed Conditions
|
Phase 1 | |
Completed |
NCT01380431 -
A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study
|
Phase 1 |